Home › Funds › Callodine Capital Management, LP › VTRS
Callodine Capital Management, LP position in VTRS
VIATRIS INC · Health Care
Callodine Capital Management, LP reported holding 8,302,927 shares of VTRS (VIATRIS INC) in its Q3 2026 13F filing — a position valued at US$147.1M, representing 9.43% of its reported portfolio and ranking #1 among its reported holdings. Callodine Capital Management, LP has disclosed VTRS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Callodine Capital Management, LP's VTRS position evolved
Callodine Capital Management, LP first disclosed a stake in VTRS in Q3 2023 at 2,320,000 shares (US$22.9M). The position peaked in Q3 2026 at 8,302,927 shares, worth US$147.1M. Across 13 filings, Callodine Capital Management, LP increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,302,927 shares valued at US$147.1M — an increase of 302,185 shares quarter over quarter.. Notable position changes include a 31% increase in Q1 2025 (shares rose 3% over the following quarter), a 65% increase in Q2 2025 (shares rose 11% over the following quarter), a 39% increase in Q4 2025 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.32M | $22.88M | New |
| Q4 2023 | 2.52M | $27.29M | Add |
| Q1 2024 | 2.30M | $27.46M | Reduce |
| Q2 2024 | 2.54M | $27.02M | Add |
| Q3 2024 | 2.69M | $31.20M | Add |
| Q4 2024 | 2.77M | $34.55M | Add |
| Q1 2025 | 3.62M | $31.57M | Add |
| Q2 2025 | 6.00M | $53.54M | Add |
| Q3 2025 | 6.94M | $68.72M | Add |
| Q4 2025 | 9.68M | $120.53M | Add |
| Q1 2026 | 8.12M | $109.68M | Reduce |
| Q2 2026 | 8.00M | $127.05M | Reduce |
| Q3 2026 | 8.30M | $147.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VTRS and 13F data
VTRS (VIATRIS INC) is a Health Care company. 32 other funds we track also report a position in VTRS — the largest reported positions include DAVIS SELECTED ADVISERS (US$1.28B), Rubric Capital Management LP (US$542.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$320.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VTRS
- DAVIS SELECTED ADVISERS 72.40M sh · $1.28B · Q3 2026
- Rubric Capital Management LP 34.17M sh · $542.60M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 20.21M sh · $320.87M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 9.88M sh · $156.85M · Q2 2026
More on Callodine Capital Management, LP
FAQ
How long has Callodine Capital Management, LP held VTRS?
Callodine Capital Management, LP has disclosed VTRS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Callodine Capital Management, LP's current position in VTRS?
As of Q3 2026, Callodine Capital Management, LP holds 8.30M shares of VTRS (VIATRIS INC), valued at $147.13M, representing 9.43% of its reported portfolio and ranking #1.
Has Callodine Capital Management, LP been buying or selling VTRS?
In the latest 13F filing (Q3 2026), Callodine Capital Management, LP increased its position in VTRS. The position peaked in Q3 2026 at 8.30M shares.
Which other funds hold VTRS?
Other major institutional holders of VTRS include DAVIS SELECTED ADVISERS, Rubric Capital Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.